UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM RW
REQUEST FOR WITHDRAWAL OF REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
PRAECIS PHARMACEUTICALS INCORPORATED
(Commission File No. 333-61225)
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 04-3200305
----------------------- -------------------
(State of incorporation (I.R.S. Employer
or organization) Identification No.)
One Hampshire Street
Cambridge, MA 02139-1572
(617) 494-8400
-----------------------------
(Address and telephone number
of principal executive offices)
NARRATIVE
Pursuant to Rules 477(a) and 478(c) under the Securities Act of 1933, as
amended, PRAECIS PHARMACEUTICALS INCORPORATED, a Delaware corporation (the
"Company") hereby requests that the Securities and Commission (the
"Commission") permit the withdrawal of the Company's registration statement
on Form S-1, File No. 333-61225, filed with the Commission on August 11,
1998, including all exhibits thereto (the "Registration Statement"). The
Company is withdrawing the Registration Statement because it does not
intend to conduct the offering of shares of common stock, par value $.01
per share, of the Company, contemplated by the Registration Statement at
this time. In addition, the Company requests that its application for
confidential treatment of certain exhibits to the Registration Statement
also be withdrawn at this time.
SIGNATURE
Pursuant to the requirements of the Securities Act of 1933,
as amended, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
PRAECIS PHARMACEUTICALS INCORPORATED
By: /s/ Kevin F. McLaughlin
----------------------------------
Name: Kevin F. McLaughlin
Title: Senior Vice President,
Chief Financial Officer,
Treasurer and Secretary
Dated: April 6, 1999
